Xencor, Inc.
Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions
Last updated:
Abstract:
The present application relates to therapeutic moieties displaying reduced immunogen response, particularly for therapeutic purposes.
Status:
Application
Type:
Utility
Filling date:
10 Aug 2020
Issue date:
8 Jul 2021